Meitav Investment House’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $494K | Sell |
|
|||||
|
2022
Q4 | $319K | Buy |
|
|||||
|
2022
Q3 | $256K | Hold |
|
|||||
|
2022
Q2 | $264K | Hold |
|
|||||
|
2022
Q1 | $257K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $325K | Hold |
|
|||||
|
2021
Q2 | $467K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $13K | Sell |
|
|||||
|
2019
Q2 | $60K | Hold |
|
|||||
|
2019
Q1 | $55K | Hold |
|
|||||
|
2018
Q4 | $39K | Hold |
|
|||||
|
2018
Q3 | $91K | Buy |
|
|||||
|
2018
Q2 | $28K | Sell |
|
|||||
|
2018
Q1 | $68K | Hold |
|
|||||
|
2017
Q4 | $85K | Buy |
|